Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478

Detalles Bibliográficos
Autores principales: Panjideh, Hossein, Niesler, Nicole, Weng, Alexander, Fuchs, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608844/
https://www.ncbi.nlm.nih.gov/pubmed/36287991
http://dx.doi.org/10.3390/toxins14100703
_version_ 1784818868606205952
author Panjideh, Hossein
Niesler, Nicole
Weng, Alexander
Fuchs, Hendrik
author_facet Panjideh, Hossein
Niesler, Nicole
Weng, Alexander
Fuchs, Hendrik
author_sort Panjideh, Hossein
collection PubMed
description
format Online
Article
Text
id pubmed-9608844
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96088442022-10-28 Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478 Panjideh, Hossein Niesler, Nicole Weng, Alexander Fuchs, Hendrik Toxins (Basel) Correction MDPI 2022-10-13 /pmc/articles/PMC9608844/ /pubmed/36287991 http://dx.doi.org/10.3390/toxins14100703 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Panjideh, Hossein
Niesler, Nicole
Weng, Alexander
Fuchs, Hendrik
Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title_full Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title_fullStr Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title_full_unstemmed Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title_short Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
title_sort correction: panjideh et al. improved therapy of b-cell non-hodgkin lymphoma by obinutuzumab-dianthin conjugates in combination with the endosomal escape enhancer so1861. toxins 2022, 14, 478
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608844/
https://www.ncbi.nlm.nih.gov/pubmed/36287991
http://dx.doi.org/10.3390/toxins14100703
work_keys_str_mv AT panjidehhossein correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861toxins202214478
AT nieslernicole correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861toxins202214478
AT wengalexander correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861toxins202214478
AT fuchshendrik correctionpanjidehetalimprovedtherapyofbcellnonhodgkinlymphomabyobinutuzumabdianthinconjugatesincombinationwiththeendosomalescapeenhancerso1861toxins202214478

Ejemplares similares